viernes, 21 de junio de 2024
Exceptional Genetics, Generalizable Therapeutics, and Coronary Artery Disease (Posted May 30, 2024 0PM)
https://phgkb.cdc.gov/PHGKB/specificPHGKB.action?topic=pgx&query=home
From the article: "The increasingly widespread availability of genomic sequencing has enabled the identification of persons and families with uniquely favorable traits, including a very low incidence of clinical events. Such exceptional persons across diverse communities are playing an important role in the genesis of medicines for common cardiovascular diseases. "
Suscribirse a:
Enviar comentarios (Atom)
No hay comentarios:
Publicar un comentario